Healthcare and Pharmaceuticals industry

Global Clostridium Difficile Diagnostics and Treatment Market Size Share Forecast 2024




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Clostridium difficile infection (CDI) is diagnosed with the help of conventional laboratory testing methods, however, rapid point-of-care diagnostic tests are also available, which can save time and costs significantly. Diagnostic assays used for detection of CDI include enzyme immunoassays (EIAs) for toxins A/B. However, these are no longer considered stand-alone primary tests due to poor sensitivity. Other tests include glutamate dehydrogenase enzyme immunoassay and molecular assay based on polymerase chain reaction. Isothermal amplification technology has also been approved by the U.S. Food & Drug Administration for diagnosis of CDI. Manufacturers such as Cepheid, BD Diagnostics, DiaSorin, Inc., Abbott Laboratories, Thermo Fisher Diagnostics, and Luminex Corporation offer advanced diagnostic tests for clostridium difficile infection. For instance, Cepheid GeneXpert test, Nanosphere Verigene SP by Luminex Corporation offer sensitivity and timely results for clostridium difficile infection.
Market Dynamics
Factors such as rising prevalence of clostridium difficile infection, availability of precise and advanced diagnostic techniques such as real time-polymerase chain reaction (RT-PCR), and presence of generic versions of standard antibiotics such as metronidazole is expected to boost growth of the clostridium difficile diagnostics and treatment market over the forecast period. Furthermore, various organizations and manufacturers are working towards increasing awareness about clostridium difficile infection and its severity. For instance, in March 2018, C Diff Foundation awarded its “Making a Difference” award to CutisPharma, Inc.—a pharmaceutical company, for contribution of the company towards increasing awareness and expanding treatment options.
Key features of the study:

This report provides in-depth analysis of clostridium difficile diagnostics and treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global clostridium difficile diagnostics and treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals, Abbott Laboratories, Trinity Biotech, Summit Therapeutics, Sanofi S.A., Novartis AG, and AstraZeneca Plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global clostridium difficile diagnostics and treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the clostridium difficile diagnostics and treatment market

Detailed Segmentation:

Global Clostridium Difficile Diagnostics and Treatment Market, By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others


Global Clostridium Difficile Diagnostics and Treatment Market, By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

Global Clostridium Difficile Diagnostics and Treatment Market, By Geography:

North America

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others


By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

U.S.
Canada


Europe

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others


By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe


Asia Pacific

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others


By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific


Latin America

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others


By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

Brazil
Mexico
Rest of Latin America


Middle East

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others


By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

GCC
Israel
Rest of Middle East


Africa

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others


By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

Central Africa
South Africa
North Africa



Company Profiles

Roche AG *

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments


Thermo Fisher Scientific
Merck & Co., Inc.
Pfizer, Inc.
Actelion Pharmaceuticals, Inc.
Abbott Laboratories
Trinity Biotech
Summit Therapeutics
Sanofi S.A.
Novartis AG
AstraZeneca Plc



 “*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Product Type
? Market Snippet, By Distribution Channel
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Impact Analysis
o Product Launches
o Pipeline Analysis
o Alternative Therapies
o Point-of-Care Vs. Conventional Diagnostic Tests
o Drug Resistant Clostridium Difficile Infection
4. Global Clostridium Difficile Diagnostics and Treatment Market, By Product Type, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o By Drug
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
? Metronidazole
? Vancomycin
? Fidaxomicin
? Bezlotoxumab
o By Diagnostic Test
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
? Enzyme Immunoassays
? Real-Time Polymerase Chain Reaction (RT-PCR)
? Nucleic Amplification Tests (NAAT)
? Others
5. Global Clostridium Difficile Diagnostics and Treatment Market, By Distribution Channel, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Hospitals & Clinics
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Diagnostic Laboratories
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Pharmacies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
6. Global Clostridium Difficile Diagnostics and Treatment Market, By Regions, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2016-2025
o North America
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? U.S.
? Canada
o Europe
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? U.K.
? Germany
? Italy
? France
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? China
? India
? Japan
? ASEAN
? Australia
? South Korea
? Rest of APAC
o Latin America
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? Brazil
? Mexico
? Rest of Latin America
o Africa
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? Central Africa
? South Africa
? North Africa
o Middle East
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? GCC
? Israel
? Rest of Middle East
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Roche AG
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Thermo Fisher Scientific
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Merck & Co., Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Pfizer, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Actelion Pharmaceuticals, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Abbott Laboratories
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Trinity Biotech Plc
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Summit Therapeutics
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Sanofi S.A.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Novartis AG
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? AstraZeneca Plc
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 37 market data tables and 43 figures on "Clostridium Difficile Diagnostics and Treatment Market - Global forecast to 2025".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.